 |
PDBsum entry 6uml
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
1089 a.a.
|
 |
|
|
|
|
|
|
|
338 a.a.
|
 |
|
|
|
|
|
|
|
25 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Ligase
|
 |
|
Title:
|
 |
Structural basis for thalidomide teratogenicity revealed by the cereblon-ddb1-sall4-pomalidomide complex
|
|
Structure:
|
 |
DNA damage-binding protein 1. Chain: a. Synonym: ddb p127 subunit,DNA damage-binding protein a,ddba,damage- specific DNA-binding protein 1,hbv x-associated protein 1,xap-1,uv- damaged DNA-binding factor,uv-damaged DNA-binding protein 1,uv-ddb 1, xpe-binding factor,xpe-bf,xeroderma pigmentosum group e-complementing protein,xpce. Engineered: yes. Protein cereblon.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ddb1, xap1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Gene: crbn, ad-006. Gene: sall4, znf797. Expressed in: escherichia coli.
|
|
Resolution:
|
 |
|
3.58Å
|
R-factor:
|
0.207
|
R-free:
|
0.267
|
|
|
Authors:
|
 |
T.L.Clayton,M.E.Matyskiela,B.E.Pagarigan,E.T.Tran,P.P.Chamberlain
|
|
Key ref:
|
 |
M.E.Matyskiela
et al.
(2020).
Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex.
Nat Struct Mol Biol,
27,
319-322.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Oct-19
|
Release date:
|
15-Apr-20
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q16531
(DDB1_HUMAN) -
DNA damage-binding protein 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1140 a.a.
1089 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Mol Biol
27:319-322
(2020)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex.
|
|
M.E.Matyskiela,
T.Clayton,
X.Zheng,
C.Mayne,
E.Tran,
A.Carpenter,
B.Pagarigan,
J.McDonald,
M.Rolfe,
L.G.Hamann,
G.Lu,
P.P.Chamberlain.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Thalidomide-dependent degradation of the embryonic transcription factor SALL4 by
the CRL4CRBN E3 ubiquitin ligase is a plausible major driver of
thalidomide teratogenicity. The structure of the second zinc finger of SALL4 in
complex with pomalidomide, cereblon and DDB1 reveals the molecular details of
recruitment. Sequence differences and a shifted binding position relative to
Ikaros offer a path to the rational design of cereblon-binding drugs with
reduced teratogenic risk.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |